Published 16:51 IST, July 19th 2020

COVID-19: In a first, India’s Case Fatality Rate falls below 2.5%, informs Health Ministry

In a significant development, India's Coronavirus fatality rate has fallen below 2.5% for the first time, the government said on Sunday

Reported by: Prachi Mankani
Follow: Google News Icon
  • share
null | Image: self
Advertisement

In a significant development, India's Coronavirus fatality rate has fallen below 2.5% for first time, government said on Sunday. India's total COVID cases rose to 1,077,618 of which 373,379 are active while 677,422 have recovered. 26,816 people have died so far.

"With effective containment strategy, aggressive testing and standardized clinical manment protocols based on holistic Standard of Care approach, Case Fatality Rate has significantly dipped. Case Fatality Rate is progressively falling and currently, it is 2.49%. India has one of lowest fatality rates in world," Ministry of Health and Family Welfare said.

Ministry furr stated that many states have conducted population surveys to map and identify vulnerable population like elderly, pregnant women and those with co-morbidities. statement added that se surveys have ensured keeping high-risk population under continuous observation, thus aiding early identification, timely clinical treatment and reducing fatalities

Advertisement

READ: COVID-recovered Delhi police personnel donate plasma at AIIMS; Union Health Min lauds m

READ: Coronavirus LIVE Updates: India's tally soars to 10,77,618; 1.37 crore samples tested

Advertisement

Seven Indian Pharma Players Race To Develop COVID-19 Vaccine

Meanwhile, at least seven Indian pharma companies are working to develop a vaccine against coronavirus as y join global efforts to find a preventive to check spread of deadly virus that has already infected more than 14 million globally. Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immulogicals, Mynvax and Biological E are among domestic pharma firms working on coronavirus vaccines in India.

Vaccines rmally require years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine within months because of pandemic.

Advertisement

READ: Seven Indian pharma players race to develop COVID-19 vaccine

READ: Indiana reports 17 more COVID-19 deaths, 855 new cases

Advertisement

16:51 IST, July 19th 2020